Suppr超能文献

静脉推注抗生素给药对脓毒症抗生素治疗延迟的影响。

Effect of IV Push Antibiotic Administration on Antibiotic Therapy Delays in Sepsis.

机构信息

Department of Pharmacy, The University of Chicago Medicine, Chicago, IL.

Department of Pharmacy, The University of Pennsylvania Health System, Philadelphia, PA.

出版信息

Crit Care Med. 2020 Aug;48(8):1175-1179. doi: 10.1097/CCM.0000000000004430.

Abstract

OBJECTIVES

Timeliness of antibiotic administration is recognized as an important factor in reducing mortality associated with sepsis. According to guidelines, antibiotics should be administered within 1 hour of sepsis presentation and the Centers for Medicare & Medicaid Services mandates administration within 3 hours. This study evaluates the difference in time from sepsis diagnosis to first-dose completion of β-lactam antibiotics between IV push and IV piggyback administration.

DESIGN

Single-center, retrospective analysis.

SETTING

Urban, tertiary-care emergency department.

PATIENTS

Inclusion criteria were as follows: 1) adult patients (n = 274) diagnosed with severe sepsis or septic shock per Sepsis-2 criteria from September to November 2016 and from September to November 2017 and 2) received β-lactam antibiotic.

INTERVENTIONS

Initial β-lactam agent administered as either IV push or IV piggyback.

MEASUREMENTS AND MAIN RESULTS

Median time (interquartile range) from sepsis diagnosis to administration of a β-lactam antibiotic was 48 minutes (19-96 min) versus 72 minutes (8-180 min) and to administration of the complete broad-spectrum regimen was 108 minutes (66-144 min) versus 114 minutes (42-282 min) in the IV push (n = 143) versus IV piggyback (n = 131) groups, respectively. When controlling for time to sepsis diagnosis and other factors, IV push was associated with approximately 32-minute time savings to β-lactam (β = -0.60; 95% CI, -0.91 to -0.29) and approximately 32-minute time savings to broad-spectrum (β = -0.32; 95% CI, -0.62 to -0.02) antibiotic administrations. The IV push group was less likely to fail the goal of β-lactam antibiotics within 1 hour (44.6% vs 57.3%; odds ratio, 2.27; 95% CI, 1.34-3.86) and 3 hours (7.6% vs 24.5%; odds ratio, 4.31; 95% CI, 2.01-10.28) of sepsis diagnosis compared with IV piggyback. The IV push strategy did not affect mortality, need for ICU admission, or ICU length of stay. No adverse events, including infusion reactions, were found in either arm.

CONCLUSIONS

Use of an IV push strategy may safely facilitate more rapid administration of β-lactam antibiotics and may allow for better compliance with sepsis management guidelines.

摘要

目的

抗生素给药的及时性被认为是降低脓毒症相关死亡率的一个重要因素。根据指南,抗生素应在脓毒症出现后 1 小时内给予,而医疗保险和医疗补助服务中心要求在 3 小时内给予。本研究评估了静脉推注与静脉滴注之间从脓毒症诊断到完成首剂β-内酰胺抗生素之间的时间差异。

设计

单中心回顾性分析。

地点

城市三级急救中心。

患者

纳入标准如下:1)2016 年 9 月至 11 月和 2017 年 9 月至 11 月期间根据脓毒症-2 标准诊断为严重脓毒症或感染性休克的成年患者(n=274);2)接受β-内酰胺抗生素治疗。

干预措施

初始β-内酰胺药物作为静脉推注或静脉滴注给予。

测量和主要结果

从脓毒症诊断到给予β-内酰胺抗生素的中位数时间(四分位距)为 48 分钟(19-96 分钟)与 72 分钟(8-180 分钟),从脓毒症诊断到给予完整广谱方案的中位数时间为 108 分钟(66-144 分钟)与 114 分钟(42-282 分钟)在静脉推注(n=143)与静脉滴注(n=131)组之间。当控制到脓毒症诊断的时间和其他因素时,静脉推注与β-内酰胺(β=-0.60;95%置信区间,-0.91 至-0.29)和广谱抗生素(β=-0.32;95%置信区间,-0.62 至-0.02)的给药时间分别节省了约 32 分钟。静脉推注组在 1 小时(44.6% vs 57.3%;优势比,2.27;95%置信区间,1.34-3.86)和 3 小时(7.6% vs 24.5%;优势比,4.31;95%置信区间,2.01-10.28)内达到β-内酰胺抗生素目标的可能性低于静脉滴注组。与静脉滴注相比,静脉推注策略并不影响死亡率、入住 ICU 的需求或 ICU 住院时间。在任何一组中均未发现不良事件,包括输液反应。

结论

使用静脉推注策略可以安全地促进β-内酰胺抗生素的更快速给药,并可能更好地遵守脓毒症管理指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验